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Abstract text
Raloxifene HCl loaded transfersomes were fabricated, optimized, and characterized as carrier for transdermal delivery to overcome the poor
bioavailabilty issue with the drug. Response surface methodology (RSM) was applied for optimization of the formulation with Box-Behnken
experimental design. Phospholipid PC90G (A), sodium deoxycholate (SDC) (B) and sonication time (C), each at three levels, were selected as
independent variables while entrapment efficiency (EE%) (Y1), vesicle size (Y2), and transdermal flux (Y3) were the response variables. The
optimized formulation was further characterized for vesicular size distribution, shape, surface morphology, and zeta-potential. Response variables
data were analyzed by Design expert® software and the best model for all three response variables was found to be quadratic. Formulation No13
with composition of 300mg PC90G (A), 35mg SDC (B) and 15min sonication time (C) was predicted as the optimized formulation. The optimized
formulation resulted a particle size of 134±9.0 nm with 91±4.9% EE%, 6.5±1.1µg/cm2/h transdermal flux, and -2.61±0.5 mV zeta potential.
Transmission electron microscopy, scanning electron microscopy, and dynamic light scattering study defined transfersomes as spherical,
unilamellar structures with a homogenous distribution and low polydispersity index (0.080±0.021). Transfersomal formulation proved significantly
superior in terms of amount of drug permeated and deposited in the skin, with an enhancement ratio of 6.25±1.5 and 9.25±2.4 when compared
with conventional liposomes and ethanolic phosphate buffer solution of the drug respectively. Confocal scanning laser microscopy proved an
enhanced permeation of coumarin-6 loaded transfersomes to the deeper layers of the skin (160 µm) as compared to the rigid liposomes (60 µm).
These in-vitro findings proved that raloxifene HCl loaded transfersomal formulation could be a superior alternative to oral delivery of the drug.
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